Consumer Goods » Food, Beverages & Tobacco | Eastgate Biotech Corp.

Eastgate Biotech Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Sales/Revenue
-
-
-
132.00
-
Cost of Goods Sold (COGS) incl. D&A
-
14.50
27.90
63.40
-
Gross Income
-
14.50
27.90
68.60
-
SG&A Expense
605.80
1,641.60
4,790.90
4,240.00
2,633.50
EBIT
605.80
1,656.10
4,818.80
4,171.40
2,633.50
Unusual Expense
-
-
-
-
184.40
Interest Expense
17.00
64.20
88.90
109.90
159.60
Pretax Income
622.80
1,720.30
4,907.70
4,281.30
2,977.50
Consolidated Net Income
622.80
1,720.30
4,907.70
4,281.30
2,977.50
Net Income
622.80
1,720.30
4,907.70
4,281.30
2,977.50
Net Income After Extraordinaries
622.80
1,720.30
4,907.70
4,281.30
2,977.50
Net Income Available to Common
622.80
1,720.30
4,907.70
4,281.30
2,977.50
EPS (Basic)
0.03
0.05
0.10
0.02
0.01
Basic Shares Outstanding
23,865.40
31,625.00
49,526.10
191,504.20
304,795.50
EPS (Diluted)
0.03
0.05
0.10
0.02
0.01
Diluted Shares Outstanding
23,865.40
31,625.00
49,526.10
191,504.20
304,795.50
EBITDA
605.80
1,641.60
4,790.90
4,127.10
2,633.50

About Eastgate Biotech

View Profile
Address
2203-65 Harbour Square
Toronto Ontario M5J 2L4
Canada
Employees -
Website http://www.eastgatebiotech.com
Updated 07/08/2019
Eastgate Biotech Corp. engages in the development of novel formulations of natural compounds and pharmaceutical products. It intends to accomplish by developing its proprietary self-emulsifying drug delivery systems, predominantly forming nanoemulsions. The company was founded on September 8, 1999 and is headquartered in Toronto, ON.